Evidence map›Paper›PMID 24098455›Full record

ArticlePloS one2013

In vivo T cell activation induces the formation of CD209(+) PDL-2(+) dendritic cells.

Matthew G Davidson, Michael N Alonso, Justin A Kenkel, Megan M Suhoski, Joseph C González, Robert Yuan, Edgar G Engleman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Matthew G DavidsonDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California, United States of America.
Michael N Alonso
Justin A Kenkel
Megan M Suhoski
Joseph C González
Robert Yuan
Edgar G Engleman
Stanford Blood Center · USStanford University · US

Funding

TLI/ATG CONDTIONING: KIDNEY/BLOOD STEM CELL TRANSPLANTSP01HL075462 · NHLBI · STANFORD UNIVERSITY · PI ENGLEMAN, EDGAR G. · 2004 to 2020
$27.9M
Lupus Glomenulonephritis and NK T cellsR01DK082537 · NIDDK · STANFORD UNIVERSITY · PI STROBER, SAMUEL · 2009 to 2013
$2.3M
Defining Adaptive Immune Mechanisms of Insulin ResistanceR01DK096038 · NIDDK · STANFORD UNIVERSITY · PI ENGLEMAN, EDGAR G. · 2012 to 2015
$1.5M
NHLBI NIH HHS HL075462NHLBI NIH HHS P01 HL075462NIDDK NIH HHS DK082537NIDDK NIH HHS DK096038NIDDK NIH HHS R01 DK082537NIDDK NIH HHS R01 DK096038
6 · The paper itself

Abstract

Two critical functions of dendritic cells (DC) are to activate and functionally polarize T cells. Activated T cells can, in turn, influence DC maturation, although their effect on de novo DC development is poorly understood. Here we report that activation of T cells in mice, with either an anti-CD3 antibody or super antigen, drives the rapid formation of CD209(+)CD11b(+)CD11c(+) MHC II(+) DC from monocytic precursors (Mo-DC). GM-CSF is produced by T cells following activation, but surprisingly, it is not required for the formation of CD209(+) Mo-DC. CD40L, however, is critical for the full induction of Mo-DC following T cell activation. T cell induced CD209(+) Mo-DC are comparable to conventional CD209(-) DC in their ability to stimulate T cell proliferation. However, in contrast to conventional CD209(-) DC, CD209(+) Mo-DC fail to effectively polarize T cells, as indicated by a paucity of T cell cytokine production. The inability of CD209(+) Mo-DC to polarize T cells is partly explained by increased expression of PDL-2, since blockade of this molecule restores some polarizing capacity to the Mo-DC. These findings expand the range of signals capable of driving Mo-DC differentiation in vivo beyond exogenous microbial factors to include endogenous factors produced following T cell activation.

Indexed as

AnimalsCD40 LigandCell Adhesion MoleculesCell DifferentiationCell MovementDC-Specific ICAM-3 Grabbing NonintegrinDendritic CellsFemaleGranulocyte-Macrophage Colony-Stimulating FactorLectins, C-TypeLymph NodesLymphocyte ActivationMiceMice, KnockoutMonocytesProgrammed Cell Death 1 Ligand 2 ProteinCD40 LigandCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinGranulocyte-Macrophage Colony-Stimulating FactorLectins, C-TypeProgrammed Cell Death 1 Ligand 2 ProteinReceptors, Cell Surface

Identifiers

PMID24098455
PMCPMC3788745
OpenAlexW2030059458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.